Madrigal Pharmaceuticals, Inc 10-K for FY2024
Madrigal Pharmaceuticals, Inc. (MDGL)
10-K
2025-02-26
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Madrigal Pharmaceuticals, Inc filed this 10-K on February 26, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $180.13M
- compared with $0 a year earlier
- Net loss
- $465.89M
- compared with a net loss of $373.63M a year earlier
- Diluted EPS
- -$21.90
- compared with -$19.99 a year earlier